Bright Minds Biosciences Inc
(DRUG)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 59,271 | 4,204 | 5,004 | 9,104 | 15,640 |
| Receivables | 295 | 37 | 27 | 122 | 87 |
| TOTAL | $60,273 | $4,400 | $5,052 | $9,354 | $15,860 |
| Non-Current Assets | |||||
| Intangibles | 0 | 0 | 0 | 2 | 2 |
| Other Non-Current Assets | 80 | 87 | 49 | 109 | 0 |
| TOTAL | $80 | $87 | $49 | $110 | $2 |
| Total Assets | $60,353 | $4,486 | $5,101 | $9,463 | $15,862 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,609 | 330 | 154 | 1,100 | 505 |
| TOTAL | $1,670 | $389 | $208 | $1,153 | $505 |
| Non-Current Liabilities | |||||
| TOTAL | $30 | $29 | $N/A | $56 | $N/A |
| Total Liabilities | $1,699 | $418 | $208 | $1,209 | $505 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | N/A | 2,367 |
| Common Shares | 88,111 | 26,033 | 25,148 | 25,239 | 21,434 |
| Retained earnings | -33,299 | -25,243 | -23,392 | -18,927 | -7,290 |
| Other shareholders' equity | 3,841 | 3,279 | 3,137 | 1,941 | 1,212 |
| TOTAL | $58,654 | $4,069 | $4,893 | $8,254 | $15,357 |
| Total Liabilities And Equity | $60,353 | $4,486 | $5,101 | $9,463 | $15,862 |